Hypera SA (HYPMY)
Hypera Market Cap: 3.703B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 3.703B |
May 16, 2024 | 3.665B |
May 15, 2024 | 3.731B |
May 14, 2024 | 3.746B |
May 13, 2024 | 3.751B |
May 10, 2024 | 3.688B |
May 09, 2024 | 3.745B |
May 08, 2024 | 3.754B |
May 07, 2024 | 3.789B |
May 06, 2024 | 3.735B |
May 03, 2024 | 3.757B |
May 02, 2024 | 3.632B |
May 01, 2024 | 3.400B |
April 30, 2024 | 3.817B |
April 29, 2024 | 3.700B |
April 26, 2024 | 3.347B |
April 25, 2024 | 3.513B |
April 24, 2024 | 3.444B |
April 23, 2024 | 3.478B |
April 22, 2024 | 3.624B |
April 19, 2024 | 3.482B |
April 18, 2024 | 3.447B |
April 17, 2024 | 3.482B |
April 16, 2024 | 3.593B |
April 15, 2024 | 3.643B |
Date | Value |
---|---|
April 12, 2024 | 3.811B |
April 11, 2024 | 3.786B |
April 10, 2024 | 3.855B |
April 09, 2024 | 4.004B |
April 08, 2024 | 3.925B |
April 05, 2024 | 3.957B |
April 04, 2024 | 4.153B |
April 03, 2024 | 3.988B |
April 02, 2024 | 4.039B |
April 01, 2024 | 3.963B |
March 28, 2024 | 4.238B |
March 27, 2024 | 4.267B |
March 26, 2024 | 4.305B |
March 25, 2024 | 4.254B |
March 22, 2024 | 4.295B |
March 21, 2024 | 4.406B |
March 20, 2024 | 4.318B |
March 19, 2024 | 4.425B |
March 18, 2024 | 4.314B |
March 15, 2024 | 4.400B |
March 14, 2024 | 4.153B |
March 13, 2024 | 4.394B |
March 12, 2024 | 4.337B |
March 11, 2024 | 4.207B |
March 08, 2024 | 4.305B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Raia Drogasil SA | 8.404B |
CEL-SCI Corp | 68.78M |
AIM ImmunoTech Inc | 20.11M |
IGC Pharma Inc | 35.69M |
NovaBay Pharmaceuticals Inc | 4.487M |
Market Cap Related Metrics
PE Ratio | 10.82 |
PS Ratio | 2.291 |
PEG Ratio | 2.021 |
Price to Book Value | 1.586 |
Price to Free Cash Flow | 10.29 |
Price | 5.85 |
Earnings Yield | 9.24% |
PEGY Ratio | 1.092 |
Operating PE Ratio | 7.238 |
Normalized PE Ratio | 10.71 |